खोज परिणाम - Lapo Alinari

परिणाम को परिष्कृत करें
  1. 1
    The clinical application of monoclonal antibodies in chronic lymphocytic leukemia

    The clinical application of monoclonal antibodies in chronic lymphocytic leukemia द्वारा Samantha Jaglowski, Lapo Alinari, Rosa Lapalombella, Natarajan Muthusamy, John C. Byrd

    प्रकाशित 2010
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Revisão
    सूची में सहेजें
    में बचाया:
  2. 2
    Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription

    Methylation of histone H3 and H4 by PRMT5 regulates ribosomal RNA gene transcription द्वारा Sarmila Majumder, Lapo Alinari, Satavisha Roy, Tyler E. Miller, Jharna Datta, Saı̈d Sif, Robert A. Baiocchi, Samson T. Jacob

    प्रकाशित 2009
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  3. 3
    Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

    Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma द्वारा Pier Luigi Zinzani, Vittorio Stefoni, Gerardo Musuraca, Monica Tani, Lapo Alinari, Annalisa Gabriele, Enrica Marchi, Stefano Pileri, Michele Baccarani

    प्रकाशित 2004
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  4. 4
    Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B‐cell non‐Hodgkin lymphoma

    Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B‐cell non‐Hodgkin lymphoma द्वारा Enrico Derenzini, Gerardo Musuraca, Stefano Fanti, Vittorio Stefoni, Monica Tani, Lapo Alinari, Filippo Venturini, Letizia Gandolfi, Michele Baccarani, Pier Luigi Zinzani

    प्रकाशित 2008
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  5. 5
    Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma

    Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma द्वारा Robert A. Baiocchi, Lapo Alinari, Mark Lustberg, Thomas S. Lin, Pierluigi Porcu, Xiaobai Li, Jeffrey S. Johnston, John C. Byrd, Kristie A. Blum

    प्रकाशित 2010
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  6. 6
    Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients

    Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients द्वारा Pier Luigi Zinzani, Monica Tani, Stefano Fanti, Lapo Alinari, Gerardo Musuraca, Enrica Marchi, Vittorio Stefoni, Paolo Castellucci, Mariapaola Fina, Mazda Farshad, S Pileri, M. Baccarani

    प्रकाशित 2006
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  7. 7
    Gemcitabine as frontline treatment for cutaneous T‐cell lymphoma

    Gemcitabine as frontline treatment for cutaneous T‐cell lymphoma द्वारा Enrica Marchi, Lapo Alinari, Monica Tani, Vittorio Stefoni, Nicola Pimpinelli, Emilio Berti, Livio Pagano, Maria Grazia Bernengo, Francesco Zaja, Serena Rupoli, Stefano Pileri, Michele Baccarani, Pier Luigi Zinzani

    प्रकाशित 2005
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  8. 8
    Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

    Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma द्वारा Pier Luigi Zinzani, Gerardo Musuraca, Monica Tani, Vittorio Stefoni, Enrica Marchi, Mariapaola Fina, Cinzia Pellegrini, Lapo Alinari, Enrico Derenzini, Antonio De Vivo, Elena Sabattini, Stefano Pileri, Michele Baccarani

    प्रकाशित 2007
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  9. 9
    Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients

    Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients द्वारा Pier Luigi Zinzani, S. Fanti, Giuseppe Battista, Monica Tani, Paolo Castellucci, Vittorio Stefoni, Lapo Alinari, Mohsen Farsad, Gerardo Musuraca, Annalisa Gabriele, Enrica Marchi, Cristina Nanni, Romeo Canini, N Monetti, Michele Baccarani

    प्रकाशित 2004
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  10. 10
    A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients

    A phase II trial of CHOP chemotherapy followed by yttrium 90 ibritumomab tiuxetan (Zevalin) for previously untreated elderly diffuse large B-cell lymphoma patients द्वारा Pier Luigi Zinzani, Monica Tani, S. Fanti, V. Stefoni, Gerardo Musuraca, Paolo Castellucci, Enrica Marchi, Mohsen Farsad, Mariapaola Fina, Cinzia Pellegrini, Lapo Alinari, Enrico Derenzini, Antonio De Vivo, F. Bacci, S Pileri, Michele Baccarani

    प्रकाशित 2008
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  11. 11
    The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation

    The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylation द्वारा Somayeh S. Tarighat, Ramasamy Santhanam, David Frankhouser, Hanna S. Radomska, Hongchang Lai, Mirela Anghelina, H Wang, Xiaomeng Huang, Lapo Alinari, Alison Walker, Michael A. Caligiuri, Carlo M. Croce, L Li, Ramiro Garzon, C Li, Robert A. Baiocchi, Guido Marcucci

    प्रकाशित 2015
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  12. 12
    Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma

    Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma द्वारा Pier Luigi Zinzani, Monica Tani, Rocco Trisolini, S. Fanti, Vittorio Stefoni, Marco Alifano, Paolo Castellucci, Gerardo Musuraca, Giorgia Dalpiaz, Lapo Alinari, Enrica Marchi, Mariapaola Fina, Cinzia Pellegrini, Mohsen Farsad, Alessandra Cancellieri, Alessandro Busca, Romeo Canini, S Pileri, Michele Baccarani, M Boaron

    प्रकाशित 2007
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  13. 13
    Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas

    Prognostic Factors in Primary Cutaneous B-Cell Lymphoma: The Italian Study Group for Cutaneous Lymphomas द्वारा Pier Luigi Zinzani, Pietro Quaglino, Nicola Pimpinelli, Emilio Berti, Gianandrea Baliva, Serena Rupoli, Maurizio Martelli, Mauro Alaibac, G. Borroni, Sergio Chimenti, Renato Alterini, Lapo Alinari, Maria Teresa Fierro, N Cappello, Alessandro Pileri, Davide Soligo, Marco Paulli, Stefano Pileri, Marco Santucci, Maria Grazia Bernengo

    प्रकाशित 2006
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  14. 14
    Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma

    Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma द्वारा Lapo Alinari, Bo Yu, Beth Christian, Fengting Yan, Jungook D. Shin, Rosa Lapalombella, Erin Hertlein, Mark Lustberg, Carl Quinion, Xiaoli Zhang, Gerard Lozanski, Natarajan Muthusamy, Mette Prætorius-Ibba, Owen A. O’Connor, David M. Goldenberg, John C. Byrd, Kristie A. Blum, Robert A. Baiocchi

    प्रकाशित 2011
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  15. 15
    Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma

    Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma द्वारा Pier Luigi Zinzani, Alessandro Pulsoni, Alessio Perrotti, Simona Soverini, Francesco Zaja, Amalia De Renzo, Sergio Storti, Vito Michele Lauta, Luciano Guardigni, Patrizia Gentilini, Alessandra Tucci, Anna Lia Molinari, Marco Gobbi, Brunangelo Falini, Pier Paolo Fattori, Fabrizio Ciccone, Lapo Alinari, Maurizio Martelli, Stefano Pileri, S Tura, Michele Baccarani

    प्रकाशित 2004
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  16. 16
    De novo <scp>CD</scp>5+ diffuse large <scp>B</scp>‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort

    De novo <scp>CD</scp>5+ diffuse large <scp>B</scp>‐cell lymphoma: Adverse outcomes with and without stem cell transplantation in a large, multicenter, rituximab treated cohort द्वारा Lapo Alinari, Alejandro A. Gru, Carl Quinion, Ying Huang, Arletta Lozanski, Gerard Lozanski, Jacqueline N. Poston, Girish Venkataraman, Eunhye Oak, Friederike Kreisel, Steven I. Park, Stephanie B. Matthews, Jeremy S. Abramson, Hana I. Lim, Peter Martin, Jonathon B. Cohen, Andrew M. Evens, Zeina Al‐Mansour, Arun Singavi, Timothy S. Fenske, Kristie A. Blum

    प्रकाशित 2016
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  17. 17
    VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia

    VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia द्वारा Steven Sher, Ethan C. Whipp, Janek S. Walker, Pu Zhang, Larry Beaver, Katie Williams, Shelley Orwick, Janani Ravikrishnan, Brandi R. Walker, Elizabeth J. Perry, Charles T. Gregory, Matthew Purcell, Alexander Pan, Pearlly S. Yan, Lapo Alinari, Amy J. Johnson, Melanie M. Frigault, Joy M. Greer, Ahmed Hamdy, Raquel Izumi, Xiaokui Mo, Deepa Sampath, Jennifer A. Woyach, James S. Blachly, John C. Byrd, Rosa Lapalombella

    प्रकाशित 2022
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  18. 18
    Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

    Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation द्वारा Lapo Alinari, Kiran V. Mahasenan, Fengting Yan, Vrajesh Karkhanis, Ji-Hyun Chung, Emily M. Smith, Carl Quinion, Porsha L. Smith, Lisa Kim, John T. Patton, Rosa Lapalombella, Bo Yu, Yun Wu, Satavisha Roy, Alessandra De Leo, Stefano Pileri, Claudio Agostinelli, Leona W. Ayers, James E. Bradner, Selina Chen‐Kiang, Olivier Elemento, Tasneem Motiwala, Sarmila Majumder, John C. Byrd, Samson T. Jacob, Saı̈d Sif, Chenglong Li, Robert A. Baiocchi

    प्रकाशित 2015
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  19. 19
    PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma

    PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma द्वारा Shelby Sloan, Fiona Brown‐Burke, Mackenzie Long, Christoph Weigel, Shirsha Koirala, Ji-Hyun Chung, Betsy Pray, Lynda Villagomez, Claire Hinterschied, Anuvrat Sircar, JoBeth Helmig-Mason, Alexander Prouty, Eric Brooks, Youssef Youssef, Walter Hanel, Samir Parekh, Wing Keung Chan, Zhengming Chen, Rosa Lapalombella, Lalit Sehgal, Kris Vaddi, Peggy Scherle, Selina Chen‐Kiang, Maurizio Di Liberto, Olivier Elemento, Cem Meydan, Jonathan Foox, Daniel Butler, Christopher E. Mason, Robert A. Baiocchi, Lapo Alinari

    प्रकाशित 2023
    पूर्ण पाठ प्राप्त करें
    Artigo
    सूची में सहेजें
    में बचाया:
  20. 20
    XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

    XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53 द्वारा Manman Deng, Mingzhi Zhang, Zijun Y. Xu‐Monette, Lan V. Pham, Alexandar Tzankov, Carlo Visco, Xiaosheng Fang, Govind Bhagat, Feng Zhu, Karen Dybkær, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, William W.L. Choi, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Michael Møller, Benjamin M. Parsons, J. Han van Krieken, Miguel Á. Piris, Jane N. Winter, Fredrick B. Hagemeister, Lapo Alinari, Yong Li, Michael Andreeff, Bing Xu, Ken H. Young

    प्रकाशित 2020
    पूर्ण पाठ प्राप्त करें पूर्ण पाठ प्राप्त करें
    Carta
    सूची में सहेजें
    में बचाया:

खोज साधन: